The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 854-859

  Villa, Luca ^a   Capitanio, Umberto ^a   Briganti, Alberto ^a   Abdollah, Firas ^a   Suardi, Nazareno ^a   Salonia, Andrea ^a   Gallina, Andrea ^a   Freschi, Massimo ^a   Russo, Andrea ^a   Castiglione, Fabio ^a   Bianchi, Marco ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a   Scattoni, Vincenzo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

biopsy; prostate; prostatic neoplasms; watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGICALLY CONFIRMED PROSTATE CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SINGLE MICROFOCUS OF PROSTATE CANCER; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; EQUIPMENT DESIGN; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84873721165     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.100     Document Type: Article

References (30)

1. J.I. Epstein, P.C. Walsh, M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
2. J.I. Epstein, D.W. Chan, L.J. Sokoll Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings J Urol 160 1998 2407
3. T.A. Stamey, F.S. Freiha, J.E. McNeal Localized prostate cancer Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 1993 933
4. M.R. Cupp, D.G. Bostwick, R.P. Myers The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis J Urol 153 1995 1543
5. H. Augustin, P.G. Hammerer, M. Graefen Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction Eur Urol 43 2003 455
6. S. Loeb, K.A. Roehl, B.T. Helfand Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection? J Urol 183 2010 112
7. M.C. Lee, F. Dong, A.J. Stephenson The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy Eur Urol 58 2010 90
8. F.K. Chun, A. Haese, S.A. Ahyai Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men Cancer 113 2008 701
9. L.M. Boccon-Gibod, O. Dumonceau, M. Toublanc Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features Eur Urol 48 2005 895
10. U. Capitanio, S. Ahyai, M. Graefen Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer Urology 72 2008 1208
11. A. Vickers, C. Bennette, G. Steineck Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial Eur Urol 62 2012 204
12. C. Jeldres, N. Suardi, J. Walz Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men Eur Urol 54 2008 1306
13. S.E. Lee, D.S. Kim, W.K. Lee Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men BJU Int 105 2010 1526
14. E.W. Steyerberg, M.J. Roobol, M.W. Kattan Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 2007 107
15. S. Roemeling, M.J. Roobol, M.W. Kattan Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations Cancer 110 2007 2218
16. M.W. Kattan, J.A. Eastham, T.M. Wheeler Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors J Urol 170 2003 1792
17. U. Capitanio, A. Briganti, A. Gallina Predictive models before and after radical prostatectomy Prostate 70 2010 1371
18. A. Heidenreich, J. Bellmunt, M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61
19. P. Harnden, B. Naylor, M.D. Shelley The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis Cancer 112 2008 971
20. P. Pepe, F. Aragona Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation Urology 70 2007 1131
21. G. Guichard, S. Larré, A. Gallina Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients Eur Urol 52 2007 430
22. V. Scattoni, M. Raber, F. Abdollah Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy Eur Urol 57 2010 1
23. N. Suardi, A. Gallina, U. Capitanio Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients Cancer 118 2012 973
24. G. Ploussard, E. Xylinas, L. Salomon The role of biopsy core number in selecting prostate cancer patients for active surveillance Eur Urol 56 2009 891
25. N.B. Delongchamps, G. de laRoza, V. Chandan Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen Prostate Cancer Prostatic Dis 12 2009 137
26. J.A. Taylor III, K.J. Gancarczyk, G.V. Fant Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer Urology 60 2002 841
27. D.J. Grossklaus, C.S. Coffey, S.B. Shappell Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores BJU Int 88 2001 722
28. J.I. Epstein, H. Sanderson, H.B. Carter Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy Urology 66 2005 356
29. U. Capitanio, P.I. Karakiewicz, L. Valiquette Biopsy core number represents one of foremost predictors of clinically significant Gleason sum upgrading in patients with low-risk prostate cancer Urology 73 2009 1087
30. L. Richstone, F.J. Bianco, H.H. Shah Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram BJU Int 101 2008 541